EPGL Update: To answer several emails, EPGL is planning to go SEC reporting within 30-45 days as of 3rd Quarter. We will keep you posted. on progress. It is the next step for EPGL in housekeeping and a top priority now. Keep in mind, the filings may happen sooner or later than the estimated time frame. We will keep shareholders up to date.
AUGUST 18, 2013 : MPDD ENDORSEMENT PAGE
NEW FOR EPGL SHAREHOLDERS: Key MPDD Endorsements Page Now Displayed on Company Website http://www.epglmed.com ;. Will Update Regularly.
PENNYPINCHED POSTED BELOW TEXT ON IHUB EPGL BOARD POST # 46510 AUGUST 23, 2013 @ 3:00:14PM IN RESPONSE MY POST # 46494
Once again, all four of the new ones. Just the text: "...Kaiser embarked on a pilot project using MPDD in patients awaiting back surgery. Kaiser is noteworthy for doing far below the national average surgeries for back pain. Criteria include pain with radiating symptoms, concordant imaging studies and failure of all possible consertive treatments. Success rates with surgery are better at Kaiser since the inclusion criteria are so onerous.
We enrolled 10 patients in the open-label pilot project and found that half of them did not require surgery with the appropriate diagnosis and treatment aimed at the muscle and not the disc, facet or nerve. Our results not only helped patients return to near normal function with less medication but also save the organization a great deal of money...
MPDD appears to offer a true advantage over conventional medical surgical care and importantly addresses the underlying pathology. I would strongly recommend this detection device and the treatment targeting the muscle for many patients suffering from chronic pain."
Bill McCarbery MD
Founder Chronic Pain Management Kaiser Permanente San Diego California "The use of the MPDD to identify muscle as the source of persistent pain in the routine physical examinations of patients in pain could result in the elimination of muscle based pain for many patients and the more discriminate utilization of surgeries and interventions performed to modulate nerve transmission as pain treatment options. The studies that he and his colleagues at NYU School of Medicine are conducting on the MPDD suggest that its wider utilization could result in both reduced suffering, improved functioning and reduced cost of care."
Rollin M. Gallagher MD, MPH
Director for Pain Policy Research and Primary Care, Penn Pain Medicine Clinical Professor of Psychiatry and Anesthesiology University of Pennsylvania Editor-in-Chief, PAIN MEDICINE
"In our study, the identification of specific muscle causing the pain led to a significantly greater and lasting reduction in pain with muscle injections, because of a more precise identification in the diseased muscle. MPDD provides information not obtainable with palpation and therefore it is now a valuable addition to our evaluation protocol and we are using it in our pain practice in the diagnosis of muscle pain problems. It is my opinion that a widespread use of MPDD could result in reduced suffering and lowered overall cost of care."
Michael Y Dubois M.D.
NYU School of Medicine Professor of Anesthesiology Director of Pain Management
"I am pleased to recommend the MPDD as a fundamental device to diagnose muscle pain. For too long, pain specialists had been overlooking the contribution that muscle pain makes to significant problems like low back pain, shoulder pain, neck pain. With the use of the MPDD we are now able to diagnose which muscles are contributing to significant pain in patients. Personally, as a physician, I have seen this device, have seen it employed and have observed the subsequent therapy focused on muscle tendon junction to improve the lifestyle of any suffering patients. Also, as a patient who has had at times debilitating muscle pain, the MPDD has been used on me to identify which muscles have contributed to significant pain in the back, leg and the shoulder. The subsequent treatment with needling and injection has contributed significantly to the improvement in my own personal health. I believe that the addition of the MPDD to the armamentarium of pain physicians to help diagnose affected muscles will greatly relieve the suffering of many patients."
News 
Market Data 
Discover 
AI
